Polar Capital Holdings PLC Celldex Therapeutics, Inc. Transaction History

Polar Capital Holdings PLC

  • $16.3 Billion
  • Q4 2024

A detailed history of Polar Capital Holdings PLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 1,565,831 shares of CLDX stock, worth $28.7 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,565,831
Previous 2,720,877 42.45%
Holding current value
$28.7 Million
Previous $92.4 Million 57.19%
% of portfolio
0.24%
Previous 0.57%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$23.31 - $32.4 $26.9 Million - $37.4 Million
-1,155,046 Reduced 42.45%
1,565,831 $39.6 Million
Q3 2024

Nov 14, 2024
SELL
$32.06 - $44.56 $11.4 Million - $15.9 Million
-355,906 Reduced 11.57%
2,720,877 $92.4 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $566,453 - $735,904
17,291 Added 0.57%
3,076,783 $114 Million
Q1 2024

May 15, 2024
SELL
$35.22 - $51.88 $2.69 Million - $3.96 Million
-76,379 Reduced 2.44%
3,059,492 $128 Million
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $16 Million - $28.8 Million
709,115 Added 29.22%
3,135,871 $124 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $254,500 - $374,600
10,000 Added 0.41%
2,426,756 $66.8 Million
Q2 2023

Dec 13, 2023
BUY
$30.29 - $38.28 $4.51 Million - $5.69 Million
148,767 Added 6.56%
2,416,756 $82 Million
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $4.51 Million - $5.69 Million
148,767 Added 6.56%
2,416,756 $82 Million
Q1 2023

Dec 13, 2023
SELL
$34.78 - $47.43 $5.52 Million - $7.53 Million
-158,767 Reduced 6.54%
2,267,989 $81.6 Million
Q1 2023

May 15, 2023
BUY
$34.78 - $47.43 $25 Million - $34.1 Million
717,989 Added 46.32%
2,267,989 $81.6 Million
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $2.81 Million - $4.59 Million
101,066 Added 6.98%
1,550,000 $69.1 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $18.2 Million - $30.1 Million
801,514 Added 123.8%
1,448,934 $40.7 Million
Q2 2022

Aug 15, 2022
SELL
$20.5 - $37.33 $12.4 Million - $22.5 Million
-602,580 Reduced 48.21%
647,420 $17.5 Million
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $6.91 Million - $9.83 Million
250,000 Added 25.0%
1,250,000 $42.6 Million
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $9.89 Million - $15.6 Million
277,157 Added 38.34%
1,000,000 $38.6 Million
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $6.45 Million - $12.5 Million
222,843 Added 44.57%
722,843 $39 Million
Q1 2021

May 17, 2021
SELL
$16.19 - $29.91 $8.1 Million - $15 Million
-500,000 Reduced 50.0%
500,000 $10.3 Million
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $15 Million - $22.8 Million
1,000,000 New
1,000,000 $17.5 Million

Others Institutions Holding CLDX

# of Institutions
199
Shares Held
60.8M
Call Options Held
960K
Put Options Held
675K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $856M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email